Based on limited published evidence, C8orf88 is annotated as a translation regulator with eukaryotic initiation factor 4E binding activity and translation repressor function. GO annotations indicate roles in negative regulation of translational initiation. A recent gastric cancer study identified C8orf88 as one of three hub genes significantly upregulated in diffuse-type gastric cancer, where it contributed to a prognostic risk model associated with poorer patient outcomes 1. However, the specific molecular mechanisms by which C8orf88 contributes to gastric cancer pathology remain unclear.